CPAP Therapy Retinal Benefits in Severe OSA: Long-Term Study

According to an Australian research group published in Investigative Ophthalmology & Visual Science, continuous positive airway pressure (CPAP) therapy is associated with slower progression of retinal vascular narrowing in patients with severe obstructive sleep apnea. The seven-year prospective study tracked a cohort to determine if protective effects observed at a two-year follow-up were maintained, offering potential insights into broader cardiovascular health.

Retinal Vascular Changes in Severe Obstructive Sleep Apnea

Severe obstructive sleep apnea has long been linked to retinal vascular changes. In the initial phases of the Australian research, investigators demonstrated progressive retinal arterial narrowing in untreated severe OSA, while treatment with CPAP appeared to reduce this narrowing over a two-year period. To evaluate long-term outcomes, the team recently published a seven-year prospective follow-up study examining the same patient cohort.

Out of the original 79 participants evaluated at the two-year mark, 39 individuals met the criteria for inclusion in the seven-year analysis. The cohort, which had a mean age of 68 years and was 66% male, included nine participants with severe OSA using CPAP, eight with severe OSA without CPAP, three with mild or moderate OSA using CPAP, 14 with mild or moderate OSA without CPAP, and five controls.

Evaluating Seven-Year Outcomes Using OCT and Fundus Imaging

Researchers utilized optical coherence tomography (OCT) and fundus imaging to measure retinal nerve fiber layer thickness, central retinal artery equivalent, central retinal vein equivalent, and the arteriovenous ratio. According to the study results, central retinal artery equivalent and central retinal vein equivalent measures were greater in patients receiving CPAP for severe OSA compared to those with untreated severe OSA.

Over the course of the seven-year study, the central retinal vein equivalent declined at a slower rate in individuals with severe OSA using CPAP than in untreated peers. Furthermore, participants with severe OSA on CPAP exhibited a notably smaller decline in central retinal artery equivalent relative to both control groups and untreated patients. Global retinal nerve fiber layer thinning rates remained equivalent across all groups, and no significant reduction in thickness was observed in the superotemporal sector for untreated severe OSA compared to the CPAP group.

Mechanisms Linking Hypoxia to Retinal and Systemic Vasculature

The research team outlined a two-pronged proposed mechanism driving retinovascular changes from recurrent apneas and hypopneas in obstructive sleep apnea. According to the authors, intermittent hypoxia and sympathetic nervous system dysfunction work in tandem to alter blood vessel structures.

“It is proposed that acute hypoxia triggers peripheral chemoreceptor activity, which increases sympathetic nervous system activity, causes episodic systemic hypertension and results in long-term structural changes in both the retinal and systemic vasculature,” the study authors explained in their paper.

Study Limitations and Implications for Cardiovascular Health

Study authors noted several limitations affecting their findings, including the loss of nearly half of the original cohort—partially driven by the COVID-19 pandemic—alongside the pooling of mild and moderate OSA groups, potential undetected OSA within the control cohort, and reliance on a 90-day compliance snapshot rather than continuous seven-year monitoring. The team pointed out that some noncompliant participants had used CPAP for several years prior to the study, which may have narrowed the observed differences between groups and suggested that the actual protective effect of CPAP could be stronger than the data shows.

Ultimately, the authors concluded that these findings support the hypothesis that CPAP therapy improves nocturnal hypoxia and mitigates retinal vascular narrowing. They noted that oculomic assessment of retinal vessels could serve as a relevant, measurable indicator of systemic cardiovascular risk and guide future research directions for patient cohorts with obstructive sleep apnea.

Frequently Asked Questions

What is the main finding regarding CPAP and retinal health?

According to the published study, continuous positive airway pressure (CPAP) therapy is associated with a slower progression of retinal vascular narrowing in patients suffering from severe obstructive sleep apnea.

How was the seven-year study conducted?

Researchers evaluated a cohort of 39 eligible participants using optical coherence tomography (OCT) and fundus imaging to analyze retinal nerve fiber layer thickness, central retinal artery and vein equivalents, and the arteriovenous ratio over a seven-year period.

What mechanism links sleep apnea to retinal vascular changes?

Study authors point to intermittent hypoxia and sympathetic nervous system dysfunction, where acute hypoxia triggers peripheral chemoreceptor activity that increases sympathetic tone and leads to structural changes in vasculature.